Relmada Therapeutics (RLMD) Return on Assets [ROA] (2013 - 2026)
Relmada Therapeutics' Return on Assets [ROA] was -26.95% in Q2 2026, up 252.79 percentage points from -279.74% a year earlier and up 8.53 percentage points from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Return on Assets [ROA] (2013 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Relmada Therapeutics came in at -82.54%, up 29.56 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -30.83 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -112.10% in FY2024 (-33.41 pp), -78.70% in FY2023 (+7.02 pp), -85.72% in FY2022 (-12.10 pp) and -73.62% in FY2021 (-21.91 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q1 2020.
- Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of -9.28 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 252.79 percentage points); the worst was Q3 2025 (a drop of 174.09 percentage points).
- Per Business Quant data, RLMD's Return on Assets [ROA] in the three quarters before Q2 2026 was -35.48% (Q1 2026), -106.00% (Q4 2025) and -312.17% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Relmada Therapeutics | 402.15 Mn | 402.15 Mn | - | -26.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.95% |
| Mar 31, 2026 | -35.48% |
| Dec 31, 2025 | -106.00% |
| Sep 30, 2025 | -312.17% |
| Jun 30, 2025 | -279.74% |
| Mar 31, 2025 | -207.37% |
| Dec 31, 2024 | -158.28% |
| Sep 30, 2024 | -138.08% |
| Jun 30, 2024 | -111.59% |
| Mar 31, 2024 | -102.81% |
| Dec 31, 2023 | -95.36% |
| Sep 30, 2023 | -96.62% |
| Jun 30, 2023 | -100.19% |
| Mar 31, 2023 | -103.93% |
| Dec 31, 2022 | -94.84% |
| Sep 30, 2022 | -77.80% |
| Jun 30, 2022 | -72.76% |
| Mar 31, 2022 | -63.05% |
| Dec 31, 2021 | -80.00% |
| Sep 30, 2021 | -111.49% |
API Access
Relmada Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();